IM Cannabis Corp.
Company Information
Industry Medicinal Chemicals & Botanical Products
SIC Code 2833
Entity Type other
SEC Category Non-accelerated filerEmerging growth company
State of Incorporation British Columbia, Canada
Business Address KIBBUTZ GLIL YAM, CENTRAL DISTRICT, L3, 4690500
Mailing Address KIBBUTZ GLIL YAM, CENTRAL DISTRICT, L3, 4690500
Phone 416-256-4202
Fiscal Year End 1231
EIN 000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 20-F Foreign company annual report | March 30, 2026 | View on SEC |
| 6-K Foreign company current report | March 17, 2026 | View on SEC |
| 6-K Foreign company current report | January 26, 2026 | View on SEC |
| 6-K Foreign company current report | January 5, 2026 | View on SEC |
| 6-K Foreign company current report | December 30, 2025 | View on SEC |
| 6-K Foreign company current report | December 12, 2025 | View on SEC |
| 6-K Foreign company current report | November 17, 2025 | View on SEC |
| 6-K Foreign company current report | November 13, 2025 | View on SEC |
| 6-K Foreign company current report | November 6, 2025 | View on SEC |
| 6-K Foreign company current report | October 29, 2025 | View on SEC |
Annual Reports
20-F March 30, 2026
- Acquired 100% ownership of Focus Medical Herbs Ltd. to consolidate profits.
- Streamlined operations by closing inactive branches to reduce overhead.
Related Companies
Companies in the same industry (SIC: 2833)
Functional Brands Inc.
MEHA Medicinal Chemicals & Botanical Products
Leef Brands Inc.
LEEEF Medicinal Chemicals & Botanical Products
Synergy CHC Corp.
SNYR Medicinal Chemicals & Botanical Products
Definium Therapeutics, Inc.
DFTX Medicinal Chemicals & Botanical Products
Glass House Brands Inc.
GLASF Medicinal Chemicals & Botanical Products
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.